Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000795878 | SCV000935357 | uncertain significance | Cryptosporidiosis-chronic cholangitis-liver disease syndrome | 2023-08-17 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 515 of the IL21R protein (p.Pro515Thr). This variant is present in population databases (rs762518345, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with IL21R-related conditions. ClinVar contains an entry for this variant (Variation ID: 642414). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IL21R protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004027544 | SCV004887645 | uncertain significance | Inborn genetic diseases | 2023-11-09 | criteria provided, single submitter | clinical testing | The c.1609C>A (p.P537T) alteration is located in exon 10 (coding exon 9) of the IL21R gene. This alteration results from a C to A substitution at nucleotide position 1609, causing the proline (P) at amino acid position 537 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |